Cynata Therapeutics (ASX:CYP) receives U.K. approval for CLI trial
- Cynata Therapeutics (CYP) has received approval from the U.K. Medicines and Healthcare products Regulatory Agency to begin the phase 2 trial of CYP-002
- This product will be used in patients with reduced blood flow in their limbs
- The company anticipates conducting the clinical trial at multiple centres in the U.K. and Australia
U.K. approval received for CLI trial
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
-0.010(4.00%) |
Mkt cap ! $43.36M | |||
| Open | High | Low | Value | Volume |
| 25.0¢ | 25.0¢ | 24.0¢ | $23.56K | 97.38K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 18606 | 24.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.5¢ | 5000 | 1 |
View Market Depth
| Last trade - 16.10pm 11/10/2024 (20 minute delay) ? |
| CYP (ASX) Chart |